Patent details

EP2802209 Title: OTIC FORMULATIONS

Basic Information

Publication number:
EP2802209
PCT Application Number:
US2013020152
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137358206
PCT Publication Number:
WO2013106230
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OTIC FORMULATIONS
French Title of Invention:
FORMULATIONS OTIQUES
German Title of Invention:
OHRENTHERAPEUTISCHE ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
03/01/2013
Grant date:
02/12/2020
EP Publication Date:
19/11/2014
PCT Publication Date:
18/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/12/2020
EP B1 Publication Date:
02/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/01/2021
Expiration date:
03/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/11/2020
 
 

Name:
Entrx LLC
Address:
1604 Bridle Path, Corsicana, TX 75110, United States (US)

Inventor

1

Name:
OGLESBEE, Vance
Address:
United States (US)

2

Name:
BRANCH, Matthew
Address:
United States (US)

Priority

1

Priority Number:
201261585031 P
Priority Date:
10/01/2012
Priority Country:
United States (US)

2

Priority Number:
201261625407 P
Priority Date:
17/04/2012
Priority Country:
United States (US)

3

Priority Number:
201261649663 P
Priority Date:
21/05/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/27; A61K 31/325; A61K 31/4174; A61K 31/496; A61K 31/573; A61K 31/7048; A61P 27/16; A61P 31/04;

Publication

European Patent Bulletin

Issue number:
202049
Publication date:
02/12/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages